CRISPR gene editing shows promise for treating individuals with a form of inherited blindness
- A clinical trial of CRISPR gene editing in 14 individuals with inherited blindness proved safe and yielded measurable improvements in 11 participants.
- All 14 participants, aged 10 to 63, had Leber Congenital Amaurosis due to mutations in the CEP290 gene.
- Eleven participants saw improvements in various outcomes, with four having improved visual acuity and six showing enhanced cone-mediated vision.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left1Leaning Right1Center6Last Updated14 days agoBias Distribution75% Center
Bias Distribution
- 75% of the sources are Center
74% Center
13%
C 74%
13%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage